Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
AIDS (London, England)|March 22, 2008
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in ZambiaMáirín Ryan, Susan Griffin, Bona Chitah, et al.British Journal of Clinical Pharmacology|July 21, 2020
Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycinMary Kelly, Ròisìn O'Connor, Liam Townsend, et al.AIDS (London, England)|November 2, 2013
Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotypeHelen M McIlleron, Michael Schomaker, Yuan Ren, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2015
Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 WeeksKimberly K Scarsi, Kristin M Darin, Shadia Nakalema, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2010
Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan womenMohammed Lamorde, Pauline Byakika-Kibwika, Violet Okaba-Kayom, et al.Malaria Journal|May 1, 2012
Pharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Jonathan Mayito, et al.Journal of Ethnopharmacology|May 11, 2010
Medicinal plants used by traditional medicine practitioners for the treatment of HIV/AIDS and related conditions in UgandaMohammed Lamorde, John R S Tabuti, Celestino Obua, et al.The Journal of Antimicrobial Chemotherapy|February 10, 2012
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Violet Okaba-Kayom, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 2, 2026
Identifying barriers to Hepatitis C virus elimination in the era of direct-acting antiviralsThomas Talbot, Gillian Farrell, Catherine Murray, et al.The Journal of Antimicrobial Chemotherapy|June 13, 2012
Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adultsPauline Byakika-Kibwika, Mohammed Lamorde, Jonathan Mayito, et al.Pageof 5